124 related articles for article (PubMed ID: 16770096)
1. [Second-line chemotherapy with pharmacokinetic modulating chemotherapy for unresectable colorectal carcinoma recurrences resistant to 5-FU-based chemotherapy].
Muneoka K; Shirai Y; Wakai T; Yokoyama N; Sakata J; Hatakeyama K
Gan To Kagaku Ryoho; 2006 Jun; 33(6):779-82. PubMed ID: 16770096
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetic modulating chemotherapy highly effective for colorectal carcinoma metastases to multiple organs].
Muneoka K; Shirai Y; Wakai T; Yokoyama N; Okumura S; Hatakeyama K
Gan To Kagaku Ryoho; 2005 Jun; 32(6):799-802. PubMed ID: 15984519
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetic modulating chemotherapy for rectal carcinoma metastases to the liver and lung--a case report].
Muneoka K; Shirai Y; Yokoyama N; Wakai T; Hatakeyama K
Gan To Kagaku Ryoho; 2005 Feb; 32(2):231-3. PubMed ID: 15751639
[TBL] [Abstract][Full Text] [Related]
4. Oral uracil/ftorafur (UFT) plus leucovorin as first-line chemotherapy and salvage therapy with weekly high-dose 5-fluorouracil/leucovorin for the treatment of metastatic colorectal cancer.
Yang TS; Wang JY; Tang R; Hsu KC; Chen JS
Jpn J Clin Oncol; 2002 Sep; 32(9):352-7. PubMed ID: 12417601
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of chemotherapy with irinotecan (CPT-11), l-leucovorin (l-LV), 5-fluorouracil (5-FU), and UFT for metastatic or recurrent colorectal cancer].
Ito T; Hata Y; Matsuoka S; Nakajima N; Yokoyama R; Honda S; Sano F; Akasaka Y; Ohmori K
Gan To Kagaku Ryoho; 2005 Sep; 32(9):1289-93. PubMed ID: 16184926
[TBL] [Abstract][Full Text] [Related]
6. [Long survival in a case of unresectable hepatic metastasis from rectal carcinoma treated with second-look hepatectomy plus pharmacokinetic modulating chemotherapy (PMC)].
Noda M; Kusunoki M; Yanagi H; Yoshikawa R; Yamamura T
Gan To Kagaku Ryoho; 2001 Jan; 28(1):99-103. PubMed ID: 11201390
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of weekly low-dose CPT-11 combined with 5-FU/l-LV therapy for advanced and recurrent colorectal cancer--preliminary study].
Tsubono M; Kaneko I; Kii E; Murata T; Deguchi Y; Sonoda K; Yasuda K
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1273-8. PubMed ID: 16969024
[TBL] [Abstract][Full Text] [Related]
8. [A case report of unresectable colon cancer that disappeared following pharmacokinetic modulation chemotherapy (PMC)].
Nakahara H; Okajima M; Nakahara M; Yano M; Asahara T
Gan To Kagaku Ryoho; 2000 Sep; 27(10):1593-6. PubMed ID: 11016008
[TBL] [Abstract][Full Text] [Related]
9. [A case of unresectable rectal cancer with liver and pulmonary metastases that responded remarkably to pharmacokinetic modulating chemotherapy].
Koyama M; Inaba Y; Watabe S; Hayashi K; Ohe S; Kamio Y; Chiba M
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1657-60. PubMed ID: 12355956
[TBL] [Abstract][Full Text] [Related]
10. Results of pharmacokinetic modulating chemotherapy in combination with hepatic arterial 5-fluorouracil infusion and oral UFT after resection of hepatic colorectal metastases.
Kusunoki M; Yanagi H; Noda M; Yoshikawa R; Yamamura T
Cancer; 2000 Sep; 89(6):1228-35. PubMed ID: 11002217
[TBL] [Abstract][Full Text] [Related]
11. Five-day continuous infusion of 5-fluorouracil and pulsed folinic acid in patients with metastatic colorectal carcinoma: an effective second-line regimen.
Streit M; Jaehde U; Stremetzne S; Ridwelski K; Kerz H; Strohbach F; Hohenberger P; Zwiebel FM; Hebart H; Böthig R; Kairies M; Zillig D; Schuchmann S; Warnecke S; Thiel E; Kreuser ED
Ann Oncol; 1997 Nov; 8(11):163-5. PubMed ID: 9426339
[TBL] [Abstract][Full Text] [Related]
12. A phase II study of continuous infusion 5-fluorouracil and leucovorin with weekly cisplatin in metastatic colorectal carcinoma.
Grem JL; McAtee N; Balis F; Murphy R; Venzon D; Kramer B; Goldspiel B; Begley M; Allegra CJ
Cancer; 1993 Aug; 72(3):663-8. PubMed ID: 8334622
[TBL] [Abstract][Full Text] [Related]
13. [A retrospective study of irinotecan plus fluorouracil and l-leucovorin chemotherapy for advanced and metastatic colorectal cancer].
Kamoshita N; Makita F; Kobayashi M; Matsuzaki Y; Kabeya K
Gan To Kagaku Ryoho; 2007 Mar; 34(3):397-401. PubMed ID: 17353631
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur.
Watanabe M; Nishida O; Kunii Y; Kodaira S; Takahashi T; Tominaga T; Hojyo K; Kato T; Niimoto M; Kunitomo K; Isomoto H; Ohashi Y; Yasutomi M
Int J Clin Oncol; 2004 Apr; 9(2):98-106. PubMed ID: 15108041
[TBL] [Abstract][Full Text] [Related]
15. The usefulness of pharmacokinetic modulating chemotherapy (UFT plus 5FU) in the treatment of unresectable colorectal carcinomas.
Kusunoki M; Yanagi H; Noda M; Yamamura T
Oncol Rep; 1999; 6(3):547-52. PubMed ID: 10203589
[TBL] [Abstract][Full Text] [Related]
16. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
17. [A case of multiple liver metastases from colon cancer successfully treated with modified pharmacokinetic modulating chemotherapy using Leucovorin].
Inoue Y; Miki C; Ojima E; Kobayashi M; Hatada T; Kusunoki M
Gan To Kagaku Ryoho; 2002 Nov; 29(11):2009-12. PubMed ID: 12465406
[TBL] [Abstract][Full Text] [Related]
18. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC
Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794
[TBL] [Abstract][Full Text] [Related]
19. Continuous delivery of venous 5-fluorouracil and arterial 5-fluorodeoxyuridine for hepatic metastases from colorectal cancer: feasibility and tolerance in a randomized phase II trial comparing flat versus chronomodulated infusion.
Focan C; Levi F; Kreutz F; Focan-Henrard D; Lobelle JP; Adam R; Dallemagne B; Jehaes C; Markiewicz S; Weerts J; Bismuth H; Jasmin C; Misset JL
Anticancer Drugs; 1999 Apr; 10(4):385-92. PubMed ID: 10378673
[TBL] [Abstract][Full Text] [Related]
20. [Retrospective analysis on efficacy and toxicity of 5-fluorouracil (5-FU) and l-leucovorin (l-LV) in advanced or recurrent colorectal cancer].
Chiba N; Yoshioka T; Kato S; Takahashi S; Shibata H; Kato S; Sakayori M; Otsuka K; Kakudo Y; Ohori H; Yamaura G; Takahashi M; Yasuda K; Ishioka C
Gan To Kagaku Ryoho; 2005 Jul; 32(7):991-5. PubMed ID: 16044961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
